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Summary: Phospholipase A2 activity in human sera was determined of the basis of the E. coli assay and
compared to a photometric micelle assay. The E. coli assay is based on the hydrolysis of phospholipids from
[l-14C]oleic acid-labelled E. coli biomembranes. In the photometric assay the phospholipase A2 acts on mixed
phospholipid micelles. The amount of fatty acid produced is quantitated in a subsequent photometric assay
by coupling in the reaction to the coenzyme A metabolism. The E. coli membranes are essentially resistent
to other Upases in human sera, i. e. lipoprotein upases, hepatic triacylglycerolipase or pancreatic lipase and
thus a very specific substrate for the phospholipase A2 of human serum. The photometric assay, though, is
susceptible to other upases in human serum. The ratio of (l-14C]oleic acid to released total fatty acids served
as the basis for the calculation of the true enzymatic activity. The assay closely correlated with the photometric
assay based on mixed micelles in the higher ranges of phospholipase A2 activity, but not in the normal range.
The sensitivity is higher by at least two powers of 10. The human serum phospholipase A2 strongly preferred
E. coli membranes as substrate to the mixed micelles containing phosphatidylcholine/phosphatidylethanolam-
ine. In conclusion, the modified phospholipase A2 assay based on E. coli membranes is a sensitive, specific,
reliable, and convenient method for the measurement of phospholipase A2 activity in human sera. The
photometric assay süffers from low sensitivity but has the advantage of practicability in a normal routine
laboratory, including the amenability to automation.
Introduction ... . , , , ,
course while others do not, and some methods are
Various efforts have been made to develop sensitive amenable to automation while others are not. How-
assays for the determination of phospholipase A23) ever, the most important consideration in the choice^
(1 — 16). The choice of a detection method depends of the detection method is the sensitivity required for
partly on the goal of a particular experiment. For the particular enzyme. The required sensitivity de-
example, some assays can be used on purified enzymes pends on the quantity of enzyme available and on its
but are incompatible with crude systems, some meth- specific activity. This point is especially important for
ods provide a continuous assay and generate a time the assay of non-pancreatic phospholipases A2 in hu-
man plasma, which are found in lower quantities and
are, in general, less active than their counterparts from
) ^Zynies1. A _ . e j ^ „ . f ,™ the pancreas or venom.Phospholipase A2 = phosphatide 2-acylhydrolase (EC
lu"1"^ · . ,_ .j . «_ /™ The sensitivity of an assay is influenced by a numberPhospholipase Aj = phosphatide 1-acylhydrolase (EC
 r r , . * t · i_ · j3.1.1.32)· °* factors, the most important of which is the detec-
Lipase = triacylglycerol aeylhydrolase (EC 3.1.1.3) tion limit of a particular method. The detection limit
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is determined by physical properties of the assay
method itself, such as the absorbance coefficient of a
chromophore or the physical limitations of the in-
strumentation. In addition to the detection limit, the
sensitivity of an assay depends on the turnover rate
of the particular enzyme, the rate of background
reaction, and, in some cases, on the assay time and
volume.
Some assays are based on artificial substrates such as
liposomes or micelles, which are possibly not the best
substrates for the phospholipase A2 in human plasma.
Synovial phospholipase A2, identical with serum phos-
pholipase A2, prefers membrane phospholipids as a
substrate (17, 18). There is some evidence that mem-
branes of Gram-negative bacteria are the natural sub-
strate of several extracellular phospholipases (19).
Other assays use membranes labelled only with one
radioactive tracer, e. g. oleic acid. They do not mon-
itor the "true activity" of phospholipase A2 because
the released but unlabelled fatty acids are not taken
into account. Therefore, it is not possible to calculate
the phospholipase A2 activity in U/l. Furthermore,
there is evidence that the phospholipase A2 activity
depends on the fatty acid composition in the sn-2
position of the phospholipid (20).
The photometric micelle assay developed by G. E.
Hoffmann (21), which has recently become commer-
cially available, suffers from lack of sensitivity for
normal and moderately elevated phospholipase A2
activity concentrations as is shown below. But it mon-
itors the true activity.
The E. coli membrane assay in the form described
represents a method that combines the advantage of
the sensitivity of a radiometric assay based on a
natural substrate, with the determination of the true
and total activity of phospholipase A2. For this pur-
pose the released radioactivity has been related to the
sum of all liberated fatty acids. The principle of this
method is the hydrolysis of radioactive oleate in the
sn-2 position of membrane phospholipids. For the
quantitation of the enzyme activity, the liberated ole-
ate has to be separated from the remaining radioactive
phospholipids. A common standard method for the
separation of the lipids is silica gel thin-layer chro-
matography following extraction from the incubation
mixture. This procedure is rather time-consuming. In
contrast, the modified E. coli method allows a re-
markable spreading of the test range and a reliable
measurement of phospholipase A2 activity in the early
stages of sickness. We compared this method with the
photometric assay (21).
Methods
E. co/f-based phospholipase A2 assay
Phospholipase A2 (EC 3.1.1.4) activity was determined by using
[l-14C]oleate-labeIled Escherichia coli (K12) as substrate with
modifications first described by Elsbach (23). The essentials of
the assay have been described earlier (24, 25). An E. coli culture
was incubated with 7.4 · 106 Bq/1 oleic acid bound to 0.4 g/1
fatty acid free bovine serum albumin for 75 min at 37 °C.
Thereafter, the bacteria were sedimented, resuspended in fresh
medium, and allowed to incorporate the rest of the labelled
precursor. The labelled bacteria were washed once with 10 g/1
albumin in saline followed by repeated washings with saline.
After centrifugation the E. coli were autoclaved for 15 min at
120 °C. This procedure inactivates bacterial phospholipases and
renders the envelope phospholipids readily accessible to the
action of serum phospholipase A2. Prior to use, the E. coli
suspension was lyophilized in appropriate aliquots in extraction
tubes. More than 95% of the incorporated label was found in
phospholipids and, as demonstrated by bee venom phospholi-
pase A2 hydrolysis, more than 95% of the [l-l4C]oleate was in
the sn-2 position, as was proven by thin-layer chromatography
(25).
The lyophilized labelled E. coli membranes (18 nmol phospho-
lipid, 180000 disintegrations per minute) were resuspended in
an assay mixture containing 100 mmol/1 Tris-HCl (pH 8.0),
5 mmol/1 CaCl2 and 20 g/i fatty acid free bovine serum albumin,
and 25 μΐ of serum or other fluids, for a final volume of 150
μΐ. Reaction mixtures were incubated at 37 °C for 15 min while
gently shaking to prevent the sedimention of the membranes.
The reaction was stopped by addition of 100 μΐ of 30 mmol/1
EDTA, and the lipids extracted with 1250 μΐ of modified
Dole (26) reagent (propane-2-ol/w-heptane/l mol/1 H2SO4,
40 + 10 + 1, by vol.) followed by 200 μΐ of heptane and 750
μΐ of H2O. After phase separation 0.5 ml of the organic phase
Tab. 1. Comparison of the procedures of the two evaluated phospholipase A2 assays: radiometric E. coli assay and the photometric
mixed micelle assay.
Radiometric E. coli assay Photometric micelle assay
Substrate
Incubation
Reaction stop
Detection procedure
Autoclaved membranes, phosphatidylethanolam-
ine : cardiolipin [80 : 20]
5 mmol/1 Ca2+, 37 °C, 15 min in the presence of
albumin (2%)
EDTA (10 mmol/1)
Radioactive free fatty acids:
— Dole's extraction
— Solid-phase extraction
— Scintillation counting
Mixed micelles, phosphatidylcholine : phospha-
tidylethanolamine [50 : 50], Triton-X, bile acids
3 mmol/1 Ca2+, 37 °C, 15 min
EDTA (8 mmol/1)
Increase in free fatty acids:
— Enzymic determination of free fatty acids
— Photometry * >
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was passed through a reusable column filled with 100 rag of
aminopropyl solid phase (Macherey & Nagel, Aachen, Ger-
many). Free [l-Ci4]oleic acid was quantitatively eluted with
diethylether/acetic acid (2%) into a scintillation vial, while
unhydrolyzed substrate remained on the column. The eluates
were counted for 3 minutes (Scintillation cocktail: Quickzint,
Zinsser-Analytic, England, Scintillation counter: LKB 1215
Rackbeta). Blank activity, resulting from residual [l-I4C]oleic
acid not incorporated into lipids, was substracted for each
sample. Enzyme activity was calculated as released fatty acids'
based on the ratio between counted radioactivity and total
liberated fatty acids as determined by HPLC (27, 28), if not
otherwise indicated. The fatty acid pattern and the relative
concentrations for serum phospholipase A2 were determined
with purified human serum phospholipase A2 as a standard, in
contrast to 1. c. (25). The phospholipase A2 was isolated and
purified from sera of intensive-care patients [manuscript in
preparation]. 1 U/l was equivalent to 4.8 χ ΙΟ6 disintegrations
per minute and litre.
Micelle phospholipase A2 assay
The activity of phospholipase A2 was determined by the pho-
tometric assay recently described by Hoffmann et al. (21).
Briefly, a lyophilized phospholipid/detergent mixture contain-
ing phosphatidylcholine, phosphatidylethanolamine (mass frac-
tion 0.5), Triton X-100 and sodium deoxycholate (Boehringer
Mannheim, Germany) was used throughout. The total liberated
free fatty acids were determined with an enzymatic test kit
(Boehringer Mannheim, Germany) based on a coenzyme A
reaction. Fatty acids are incorporated into acyl-CoA using acyl-
CoA synthetase, then oxidized to 2,3-r/Yzn.s-enoyl-CoA with
acyl-CoA oxidase. The peroxide generated in the latter step
leads to the formation of a chromophore by oxidative coupling
of an aminoantipyrine and a phenol derivative. Alternatively,
the fatty acids were quantitated separately by the HPLC method
(27, 28). For direct comparison, the E. coli assay and the
photometric micelle assay are described in table 1.
Acute phase proteins
The acute phase proteins, C-reactive protein and serum amyloid
A, were determined by nephelometry (Behring, Marburg, Ger-
many). The antiserum against serum amyloid A was a friendly
gift of the Behring company.
Results
Character of the substrate
We investigated the E. coli assay for interference from
various Upases. Human serum contains several upases
and phospholipases, i.e. lipoprotein lipase, hepatic
triacylglycerolipase, pancreatic lipase, which might
influence the accuracy of the assay. Therefore, E. coli
membranes were incubated with different (phos-
pho)lipases. The phospholipids of E. coli membranes
were either labelled with [l-14C]palmitic acid in the
sn-\ position or with [l-14C]oleic acid in the sn-2
position (tab. 2). Control labelling of the sn-\ position
was insofar important as the radioactive oleic acid
was also incorporated into the sn-\ position (5 to 10
percent), and high activity of phospholipase AJ might
simulate phospholipase A2 activity. To check the ef-
fects of serum lipoprotein lipases the E. coli mem-
branes were incubated with sera from healthy vol-
unteers after a bolus injection of heparin (5000 i.U.,
i.v.) collected after 10 min. Those sera are rich in
lipoprotein lipase and hepatic triacylglycerolipase.
Tab. 2. The specificity of the E. coli membranes as substrate for the serum phospholipase A2 activity was verified by incubation
with different (phospho)lipases. For this purpose, the phospholipids of E. coli membranes were labelled either with [1-
14C]palmitic acid in the sn-1 position or with [l-14C]oleic acid in the sn-2 position to the ratio indicated in the table. To
check the activity of serum lipases on the E. coli membrane healthy volunteers (n = 3) were heparinized with 5000 i. U.
of heparin and blood was drawn after 10 min. Such sera are rich in lipoprotein lipases and hepatic triacylglycerolipase.
The latter exhibits mainly phospholipase AI activity. Sera of intensive-care patients (n = 3) with nearly the same activity
on the micellar substrate were chosen for comparison. Additionally, pancreatic lipase was added to a normal serum and
tested for the release of radioactive fatty acids from the E. coli membranes. The sera of healthy volunteers (n = 3) served
as controls.
Release of fatty acids from the phospholipids
Micelle assay Escherichia ce//-based assay
•
Sera of healthy volunteers before heparin (n = 3)
Sera of healthy volunteers 10 min after
heparin 5.000 Ϊ. E. (n = 3)
Phospholipase A2^rich sera of intensive-care
patients (n = 3)
Normal sera enriched with pancreatic lipase
[1000 U/l] without colipase (n = 3)
Labelling ratio of sn-2 and sn-\ position
Total fatty acids
μιηοΙ/1/min
0.05 ± 0.01*
20.4 ± 1.0
20.0 ± 1.5
[l-!4C]01eic acid
nmol/1/min
5.1 ± 0.2
5.7 ± 0.3
1360 ± 120
5.3 ± 0.4
95: 5
[l-!4C]Palmiticacid-
nmol/1/min
0.7 ± 0.2
3.6 ± 0.4
270 ± 21
6.4 ± 0.5
20:80
* 24 h incubation
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The latter exhibits mainly phospholipase A, activity.
Its activity on the micelle substrate was about 20
μηηοΐ/min · 1. The release of the labelled oleic acids
was on the same order of magnitude as in the sera of
healthy volunteers without heparin application, and
somewhat higher for the labelled palmitic acid. This
demonstrates a considerable resistence of the E. coli
membranes to the activities of phospholipase A! and
the lipoprotein lipase. Control experiments were done
with phospholipase A2-rich sera from intensive-care
patients. The sera were diluted to approximately 20
U/l (332 nkat/1) as determined by the photometric
micellar assay. Radioactive oleic acid was released
from the sn-2 position, as expected. The liberation of
labelled palmitic acid can be explained by the co-
labelling of the sn-2 position. This effect reflects ex-
actly the ratio of the label between the sn-\ and sn-2
position. Acute pancreatitis often proceeds with an
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Fig. 1. Linearity of the phospholipase A2 assays.
a) The linear range for serum phospholipase A2 was
established by serial dilution ^. The cut-off value for
the photometric micelle assay was 58 U/l (967 nkat/1).
b) Using the E. coli assay the linear range was estab-
lished in the same manner o. The cut-off value for the
radiometric E. coli assay of human serum was 7.2 μήιοί/
min · l (120 nkat/1).
Additionally, the linear range was determined with pu-
rified phospholipase A2 isolated from human sera with
high phospholipase A2 contents φ. The activity of pu-
rified human serum phospholipase A2 was found to be
linear up to 14.4 U/l (240 nkat/1).
increase in phospholipase A2, and it is important to
distinguish this activity from that of the pancreatic
lipase. Therefore, we incubated the labelled mem-
branes with normal serum spiked with pancreatic
lipase to 1000 U/l (16667 nkat/1). As shown in table
2 the release of labelled fatty acids is barely different
from that of normal sera.
Analytical properties
Linearity
Using sera from septic patients the linear r nge for
serum phospholipase A2 activity was established up
to 7.2 U/l (120 nkat/1) (fig. 1) corresponding to a
hydrolysis rate of 8%. Under assay conditions the
curve deflected from linearity at 42 χ 106 disintegra-
tions per minute and litre. To monitor the enzyme
activity beyond this range, the sera of patients with
septicaemia and polytraumatic shock must be diluted
many times. Surprisingly, the activity of purified hu-
man serum phospholipase A2 was found to be linear
up to a hydrolysis rate of 16%, corresponding to^f4:4
U/l (240 nkat/1). Spontaneous hydrolysis of mem-
brane phospholipids was not observed. The range of
the photometric micelle assay was found to be linear
up to 60 U/l (1000 nkat/1) (21).
Reliability
Quality control data for intra-assay and inter-assay
imprecision for the E. coli and the photometric micelle
assay, resp. are given in table 3.
Tab. 3. Inter-assay imprecision of the radiometric phospholi-
pase A2 assay with E. coli membranes and the photo-
metric micelle assay [U/l].
Radiometric E. coli assay
Intra-assay imprecision51 Inter-assay imprecision0
Mean
[U/l]
0.32
3.1
7.7
SD
[U/l]
0.018
0.11
0.22
CV
(%)
5.8
3.5
2.9
Mean
[U/l]
0.65
3.3
7.1
SD
[U/l]
0.063
0.21
0.38
CV(%)
9.7
6.3
5.4
Photometric micelle assay
Intra-assay imprecision81 Inter-assay imprecision5
Mean
[U/l]
17.8
40.7
SD
[U/l]
1.58
1.42
CV
(%)
8.9
3.5
Mean
[U/l]
16.8
42.5
SD
[U/l]
1.62
2.83
CV
(%)
9.6
6.6
a
 Intra-assay imprecision was determined with three different
serum pools (n = 12 in each case);
b
 Inter-assay imprecision was determined with three other dif-
ferent serum pools (n = 20 in each case)
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Sensitivity
The limit of detection for the photometric micelle
assay was established using various concentrations of
fatty acids in samples free of phospholipase A2 activ-
ity. This was done in contrast to Hoffmann et al. (21)
who verified the detection limit using water instead
of serum. The detection limit depended on the fatty
acid concentration and increased from 5.1 U/l (85
nkat/1) (without fatty acids in the sample) to 12.7 U/l
(212 nkat/1) (fatty acid concentration 2150 μηαοΐ/ΐ in
the sample) (fig. 2). The radiometric E. coli assay was
almost independent of the fatty acid concentration,
and the detection limit was 0.35 U/l (5.8 nkat/1) (fig.
2). It has to be mentioned that the activities obtained
by both assays are not exactly comparable because
the substrates for the assays are different.
.1
14
12
1
§=•10
•ηsit
'Sο
12:
7.9
0.3 0.2S 035 0.35
356 1000
Free fatty acid concentration [prnol/l]
2150
Fig. 2. Detection limits for the E. coli assay (^ — φ) and the
photometric micelle assay (D — D) were established using
various concentrations of fatty acids in the sample with-
out phospholipase A2 activity (abscissa). The detection
limits of each point is given as mean + 3 s (standard
deviations).
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a) Phospholipase A2 activity in sera from healthy male
(n = 43) and female volunteers (n = 55) and intensive-
care patients (n = 36). The boxes show the median and
the 2.5 to 97.5 percentile range of the results. In the
Mann- Whitney two sample test the differences between
the groups were statistically significant (** p < 0.01,
*** p < 0.001),
b) Using the photometric assay the reference ranges
were established with the same specimens. No statistical
difference could be observed between the male and
female groups.
Reference range and patients
Sera from healthy volunteers and intensive-care pa-
tients were analyzed with the E. coli method (fig. 3a)
and compared to the photometric assay. Reference
ranges (2.5 to 97.5 percentile) were established in
healthy women (n = 45) as 0.088-2.22 U/l (1.46-
36.8 nkat/1) and in healthy men (n = 40) as lower
than 0.88 U/l (14.66 nkat/1). In the unpaired non-
parametric test (Mann-Whitney) the medians of
healthy males and females were significantly different
(p < 0.001). This is the first observation of sex-spe-
cific reference ranges for serum phospholipase A2, but
at present nothing can be said about this difference
or its clinical implications. In addition, patients with
pathologically high phospholipase A2 activities were
investigated to demonstrate the applicability of this
assay. Sera of intensive-care patients (n = 36) suffer-
ing from septicaemia, pancreatitis, acute lung failure
and other diseases reached values up to 1080 U/l
(18 000 nkat/1).
For the photometric assay, we plotted the phospho-
lipase A values of the same healthy volunteers (fig.
3b). The seeming reference range extended from 2 to
9 U/l (2.5 to 97.5 percentile). The free fatty acid
concentrations of all volunteers were below 700
μπιοΐ/ΐ. No sex-specific differences could be observed.
The sera of the patients of the intensive-care unit
reached values up to 290 U/l (4865 nkat/1). Actually,
the reference range must be estimated with the sen-
sitivity range corresponding to the actual fatty acid
concentration in the specimen, i.e. probably below
7.9 U/l (132 nkat/1) for low fatty acid concentration
and below 12.7 U/l (212 nkat/1) for high fatty acid
concentration. Values below 7.9 U/l (132 nkat/1) have
to be considered as accidental.
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Correlat ion of the E. coli assay with the
micelle assay
The photometric micelle assay lacks analytical sensi-
tivity in the normal and moderately elevated phos-
pholipase A2 range. For this reason we compared
both methods at higher phospholipase A2 ranges only.
The results obtained are plotted in figure 4. They
demonstrate an unexpectedly high correlation
(r = 0.97, p < 0.001). However, the slope (4.1) indi-
cates the obvious preference of phospholipase A2 for
the membraneous substrate. This may partly be
caused by the substrate composition, implying that
phosphatidylethanolamine is possibly preferred over
other phospholipids e.g. phosphatidylcholine. The
micellar substrate contains phosphatidylcholine and
phosphatidylethanolamine in a mass ratio of 1:1,
since phosphatidylcholine was not hydrolized and is
thus not a suitable substrate for phospholipase A2
(29). The phospholipase A2 activity, though, is largely
dependent on the composition and conformation of
the substrate (30).
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Fig. 5. Typical time course of acute phase proteins of a poly-
traumatized patient beginning with time of admission:
B phospholipase A2 (photometric micelle assay);
φ· phospholipase A2 (radiometric E. coli assay);
* serum amyloid A;
D C-reactive protein.
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Fig. 4. Comparison of the E. coli-based radiometric assay and
the micelle assay for the determination of phospholipase
A2 activity in human sera. The micelle assay showed
markedly lower activity than the membrane assay.
R = 0.97; y = 4.1x-15.3; N = 55. For comparison,
only phospholipase A2 activity above 15 U/l was taken
because of the detection limit of the photometric assay.
Comparison to other acute phase proteins
Figure 5 demonstrates a typical time course of acute
phase proteins of a polytraumatized patient from the
time of admission. The kinetics of C-reactive protein,
serum amyloid A, and phospholipase A2 measured by
the E. coli assay paralleled each other well in the
initial phase, whereas the phospholipase A2 deter-
mined by the photometric micelle assay shows seen>
ing lag phase. The phospholipase A2 determined by
the photometric assay showed a significant increase
only 24 to 32 h after the event, whereas the E. coli
assay reacted with a ten-fold increase after 8 h, similar
to the kinetics of C-reactive protein and serum amy-
loid A.
Discussion
The selection of a membrane fatty acid labelled phos-
pholipid substrate from E. coli allows an approxi-
mation of the physiological array of phospholipids
and may avoid inherent problems associated with the
physicochemical characteristics of synthetic sub-
strates. The disadvantages are that the phospholipid
composition is controlled by E. coli and can only be
controlled with differently, using highly sophisticated
growth conditions. Secondly, the amount of phospho-
lipid substrate present in the assay is extremely low.
On the other hand, the characteristics of phospholipid
micelles, i. e. packing density and lipid surface charge,
can also have marked effects on phospholipase A2
activation and hydrolysis (8, 30). These circumstances
make a standardization of a catalytic assay quite
difficult.
This work indicates that phospholipase A2 activity in
human serum hydrolyzed phosphatidylcholine/phos-
phatidylethanolamine/deoxycholic acid/Triton X^lOO
mixed micelles poorly, and that a t claved E. coli
membranes containing primarily radio-labelled phos-
phatidylethanolamine were readily hydrolyzed by the
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enzyme, thus providing the basis for a sensitive assay
system. Similar results were described by Parks et al.
(31). There is no preference of any acyl chain in the
sn-2 position (33), in contrast to phospholipases A2
from platelets and rheumatoid synovial fluid (2, 20).
Another problem is inherent to the micellar photo-
metric assay, which is based on the determination of
total fatty acids including those present in the serum
of the patient as so-called free fatty acids before the
phospholipase A2 assay. The sera of intensive-care
patients often contain high free fatty acid concentra-
tions and the additionally liberated fatty acids from
the phospholipase A2 activity contribute little to an
increase in the total free fatty acids (e. g. corresponds
the free fatty acid concentration of about 2500 μιηοΐ/ΐ,
not uncommon in sera of intensive-care patients, to
an absorbance of 0.417). A phospholipase activity of
8 U/l (133 nkat/1) causes an increase in absorbance of
0.020 over a period of 15 min (0.0013/min). The
increase amounts to less than 5%. The multiple steps
of the assay (21), which are impeded often by a lack
of automation, imply that the increase in the phos-
pholipase activity can not reliably be distinguished
from the basal free fatty acid concentration, since low
differences of absorbance lie within the sensitivity
range. This explains why it is not possible to determine
phospholipase A2 activity below 8 U/l (133 nkat/1) by
the photometric micelle assay with an acceptable ac-
curacy. In comparison, the upper limit of the linear
range of the E. coli assay was 7.2 U/l (120 nkat/1)
and the assay shows good spreading in this range.
The preference for E. coli membranes as substrate
suggests that the enzyme may function in the host
defence against Gram-negative bacteria (19). Assum-
ing that the polymorphpnuclear leukocytes represent
one possible source of serum phospholipase A2 (7),
serum phospholipase A2 may be highly specific for
Gram-negative membranes, and even more so after
activation of phospholipase A2 by the bactericidal/
permeability-increasing protein (32).
It was possible to demonstrate that the E. coli mem-
brane assay was very specific for the phospholipase
A2 of human serum and relatively insensitive to other
lipases in human sera, i. e. lipoprotein upases, hepatic
triacylglycerolipase or pancreatic lipase. Although the
activity of phospholipase At (hepatic triacylglycero-
lipase) from human serum on E. coli membrane phos^
pholipids appears to be very low in terms of cleaved,
labelled fatty acids, the hydrolysis of the sn-\ fatty
acids resulted in a slight increase in radioactive lyso-
phosphatidylethanolamine as assessed by the release
of [14C]palmitic acid (see tab. 2: 0.7 vs. 3.6 nmol/
min -1). Only 5% to 10% of the fatty acid label is
incorporated into the m-\ position, and lyso-phos-
phatidylethanolamine is retained by the solid-phase
column technique for the separation of fatty acids.
Consequently, it does not contribute to the result.
In comparison, the photometric micelle assay is not
affected by the phospholipase Aj activity of the spec-
imen, as we have recently demonstrated (33). The
influence of therapeutic heparinization on phospho-
lipase A activity was investigated in healthy volunteers
who received an intravenous bolus injection of 5000
i.U. of heparin. Total phospholipase A activity 10
min after injection increased up to 22 U/l and dropped
to < 5 U/l after several hours.
Activity was expressed accounting for the sum of the
released fatty acids. In previous publications (29, 34)
the phospholipase A2 activity of the radiometric E.
coli assay was expressed as the hydrolysis rate based
only on the rate of release of the labelled fatty acids.
This renders comparison and longitudinal studies
questionable because of the possible variability in the
degree of specific labelling from lot to lot. A recent
paper focussing on the comparison of the radiometric
assay and the photometric assay dealt only with the
correlation of the patients' results (35). The authors
obtained a similar high correlation of the two meth-
ods. In addition, the concordance of each pair of
values was extremely good even on the basis of the
measured activity. But the authors did not comment
on the determination and calibration of the true ac-
tivity of the enzyme on the E. coli membranes. We
were able to demonstrate an obvious preference of
the enzyme for the membranous substrate (fig. 4)
resulting in activity four times as high. This, in turn,
contributes additionally to the higher sensitivity of
the biomembrane assay.
The relatively small linear range of serum phospho-
lipase A2 compared to purified phospholipase A2 from
human plasma might be explained by the presence of
an inhibitor. Besides lipocortins, lipoproteins may
play an important role in the mechanism of inhibiton
(36). The same phenomenon may also be responsible
for the relatively low activity of serum phospholipase.
A2 on mixed micelles where the serum fraction is
markedly higher.
The concordant kinetics of phospholipase A2 activity
and the other acute phase proteins (serum amyloid A
and C-reactive protein) in the time-course study are
compatible with the conclusion that phospholipase A2
in human plasma has its origin in the hepatocytes,
and can be considered as an acute phase protein itself.
This hypothesis has been supported by Crowl et al.
(17) who were able to demonstrate a common genetic
regulation of phospholipase A2 and of the above-
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mentioned acute phase proteins in HepG2 cells. And
indeed, we very recently were able to prove the ex-
pression and secretion of phospholipase A2 in primary
human hepatocytes (data not yet published).
In conclusion, the E. a?//-based assay is more reliable
and more sensitive than the photometric micelle assay
for the determination of the specific activity of phos-
pholipase A2 in human serum. The membrane sub-
strate is easily prepared. The reference range is below
2.22 U/l (37 nkat/1). With the method described the
activities of phospholipase A2 of human serum sam-
ples can be reliably determined. The inter- and in-
traassay imprecisions were below 5% and 10%, resp.
Pathologically elevated phospholipase A2 activity in-
creased up to 500-fold above the reference range, with
indicates a high diagnostic potential.
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